Almac Group

(Image: Getty/Oatawa)

Almac expands neo-antigen peptide manufacturing

By Maggie Lynch

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.

(Image: iStock/scanrail)

Almac announces £27m global expansion

By Melissa Fassbender

The Almac Group is planning to expand its operations in Europe and North America with an investment totaling £27m across three sites.

Almac first established its presence in the US in 1996 with clinical trial operations in Audubon, Pennsylvania. (Image: iStock/tongdang5)

Almac Group announces $5.2m expansion

By Melissa Fassbender

In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers